Verve Therapeutics, Inc.
USD11.13
+0.03 (+0.27%)
CEO
Sekar Kathiresan
IPO Date
2021-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.13
Prev. Close
$11.10
Day Low
$11.13
Day High
$11.13
52W Low
$2.87
52W High
$11.40
Market Cap
$0.99B
Volume
10.31M
| 136,139 |
| $5.02 |
| 28 Jul 2025 | MacLean Michael F | director | D-Return | Disposed | 42,200 | $5.73 |
| 28 Jul 2025 | Yeshwant Krishna | director, 10 percent owner: | U-Tender | Disposed | 1,800,000 | $10.50 |
| 28 Jul 2025 | Yeshwant Krishna | director, 10 percent owner: | D-Return | Disposed | 136,139 | $5.02 |
| 28 Jul 2025 | Yeshwant Krishna | director, 10 percent owner: | D-Return | Disposed | 42,200 | $5.73 |
| 28 Jul 2025 | Dorval Allison | Chief Financial Officer | U-Tender | Disposed | 13,280 | $10.50 |
| 28 Jul 2025 | Dorval Allison | Chief Financial Officer | D-Return | Disposed | 75,000 | $6.01 |
| 28 Jul 2025 | Dorval Allison | Chief Financial Officer | D-Return | Disposed | 1,875 | $0.00 |
| 28 Jul 2025 | Dorval Allison | Chief Financial Officer | D-Return | Disposed | 180,000 | $12.75 |